Specific full-nutrient formula weight-losing and fat-reducing food applied to large health industry

Abstract

The invention relates to a weight-losing and fat-reducing food with a specific full-nutrition formula applied to the large health industry, and belongs to the technical field of formula foods with special medical purposes. According to the food, marine active substances (algal polysaccharides and chitin) and medicinal and edible components serve as cores, lotus leaves, hawthorn fruits, cassia seeds, poria cocos and the like are compounded, and the bioavailability is improved through a nano-carrier technology; the product comprises a total nutrient base material (15-20% of protein, 10-15% of dietary fiber, and complex vitamins and minerals), functional components (5-8% of a marine active extract and 3-5% of a traditional Chinese medicine extract), and a metabolism regulator (2-3% of conjugated linoleic acid). The activity is retained through low-temperature enzymolysis and microcapsule embedding processes, and the product meets the GB 29922-2013 special medical food standard, has the functions of nutrition support and metabolism regulation, and fills the market blank of the special medical food for losing weight and reducing fat.

Description

Technical Field

[0001] The present invention belongs to the technical field of foods for special medical purposes (FSMP), and specifically relates to a complete nutritional formula food for patients with obesity and metabolic syndrome, which combines weight management and basic nutritional support functions. Background Art

[0002] Existing weight loss and fat reduction products have the following problems: 1. Ordinary meal replacements: nutritional imbalance, long-term use can easily lead to trace element deficiencies; 2. Traditional Chinese medicine weight loss preparations (such as the patent of Guangxi University of Chinese Medicine): lack a complete nutritional ratio and cannot meet the needs of postoperative patients; 3. Foods for special medical purposes (e.g. GB 29922-2013): Existing products are mostly targeted at diabetes or kidney disease, and there is no special medical formula specifically for weight loss and fat reduction.

[0003] In addition, the application of marine active ingredients in traditional weight loss products is insufficient. Seaweed polysaccharides can inhibit fat absorption by regulating intestinal flora, and chitin can bind to dietary fat and excrete it from the body. The two can work together to improve fat reduction efficiency. Summary of the Invention

[0004] The present invention proposes the following innovative solutions: 1. Formula Design: Based on ingredients from the "medicine and food" catalog (lotus leaf, hawthorn), combined with marine active ingredients, and enhanced targeting through nanotechnology; 2. Process innovation: low-temperature enzymatic hydrolysis is used to preserve protein activity, and microencapsulation is used to solve the bitterness problem of traditional Chinese medicine ingredients; 3. Functional verification: Animal experiments have confirmed that it can downregulate PPAR-γ gene expression and inhibit adipocyte differentiation. DETAILED DESCRIPTION

[0005] Example 1 - Formulation Example: - Take 18g of whey protein, 6g of seaweed polysaccharide, 4g of chitin, 2.5g of nuciferine, and 2g of CLA, mix them with vitamin and mineral premix to make a 30g granule per package.

[0006] Example 2 - Clinical application: - Obese patients who replaced two meals a day (300kcal each) saw an average reduction of 8.3cm in waist circumference and a 23.7% decrease in low-density lipoprotein after 8 weeks. clinical trials

[0007] The trial was conducted in a hospital that cooperated with Shanxi Tongwen Vocational and Technical College: - Grouping: 60 cases in the experimental group (this product) and 60 cases in the control group (commercially available meal replacement); - Results: After 12 weeks, the body fat percentage of the experimental group decreased by 12.4% (6.8% in the control group), and the incidence of gastrointestinal adverse reactions was only 3.3% (15% in the control group). BRIEF DESCRIPTION OF THE DRAWINGS

[0008] Figures 1-3 The schematic diagram shows the process flow, microstructure and clinical data. Remarks

[0009] The invention has completed 9 months of uninterrupted comprehensive animal experiments in a national animal laboratory of a hospital and has passed the genetic testing work of a genetic testing unit.

Claims

1. A specific complete nutritional formula weight loss and fat reduction food, characterized in that Contains the following components (by weight percentage): - Complete nutritional base: whey protein 15-20%, oat beta-glucan 10-15%, complex vitamins (A, D, E, B complex) 1-2%, minerals (calcium, iron, zinc) 0.5-1%; - Functional components: seaweed polysaccharide 5-8%, chitin 3-5%, nuciferine extract 2-3%, hawthorn flavonoids 1-2%, cassia anthraquinone 0.5-1%; - Metabolic regulators: Conjugated linoleic acid (CLA) 2-3%, L-carnitine 1-1.5%.

2. The weight-loss and fat-reducing food according to claim 1, characterized in that: - The seaweed polysaccharide is a sulfated polysaccharide extracted from deep-sea brown algae with a molecular weight of 10-50kDa; - The chitosan is deacetylated, with a deacetylation degree of ≥85%.

3. The weight-loss and fat-reducing food according to claim 1, characterized in that: - The nuciferine extract is extracted using supercritical CO2, with a purity of ≥90%; - The hawthorn flavonoids and cassia seed anthraquinone are embedded in nanoliposomes, with a particle size of ≤100nm.

4. The method for preparing the weight-loss and fat-reducing food according to claim 1, comprising the following steps: - S1. Mix seaweed polysaccharides, chitin, and whey protein and subject them to low-temperature enzymatic hydrolysis (45°C, pH 6.5) for 2 hours; - S2. Nuciferine, hawthorn flavonoids, cassia anthraquinone, and conjugated linoleic acid were prepared into microcapsules (the wall material was a gum arabic-gelatin composite); - S3. Homogenize and mix the complete nutritional base, functional components and metabolic regulators, spray-dry into powder or compress into solid tablets.

5. The preparation method according to claim 4, characterized in that: - The final product must meet the energy density (1.0-1.5kcal / mL) and osmotic pressure (300-450mOsm / L) requirements for specific nutritionally complete formula foods in GB 29922-2013.

Images